This second edition of Clinical Use of Anti-Infective Agents provides a comprehensive overview of current approaches to using drugs to treat infections, including historical perspectives, definitions, and discussion of pharmacokinetics and pharmacodynamics and their uses. It includes a detailed explanation of different classes of drugs, outlining their spectrum, pharmacokinetics, side effects, and dosing in clinical settings. This book has been designed as a reference tool for pharmacists, clinicians, nurse practitioners, and clinical microbiologists, as well as a teaching vehicle for students…mehr
This second edition of Clinical Use of Anti-Infective Agents provides a comprehensive overview of current approaches to using drugs to treat infections, including historical perspectives, definitions, and discussion of pharmacokinetics and pharmacodynamics and their uses. It includes a detailed explanation of different classes of drugs, outlining their spectrum, pharmacokinetics, side effects, and dosing in clinical settings. This book has been designed as a reference tool for pharmacists, clinicians, nurse practitioners, and clinical microbiologists, as well as a teaching vehicle for students studying infection and patient treatment.
Each section includes references allowing for in-depth study of specific agents, Q&As, and illustrative case studies accompanied by commentary on how to approach patients and organisms, optimal methods of making a diagnosis, and prescribing treatment.
Robert W. Finberg Richard Haidack Professor and Chair Department of Medicine University of Massachusetts Medical School Worcester, MA, USA Robert.Finberg@umassmed.edu Roy Guharoy System Vice President Baptist Health System, Montgomery, AL UMass Memorial Health Care Clinical Professor of Medicine University of Massachusetts Medical School Worcester, MA, USA Roy.Guharoy@umassmemorial.org
Inhaltsangabe
1. Introduction and history.- 2. Basic principles of drug delivery and dosing.- 3. Sulfonamides.- 4. Penicillins.- 5. Cephalosporins.- 6. Monobactams: Aztreonam.- 7. Carbapenems.- 8. Glycopeptides and other agents used to treat gram-positive cocci.- 9. Vancomycin: New Area-under-the-curve-based therapeutic monitoring.- 10. Aminoglycosides.- 11. Macrolides.- 12. Metronidazole and clindamycin.- 13. Quinolones.- 14. Tetracyclines.- 15. Pleuromutilin.- 16. Antimicrobial stewardship: evolution into the 21st century.- 17. Clinical approach to the treatment of infectious diseases.- 18. Understanding drug allergies and drug toxicities.- 19. Antibiotic-associated diarrhea.- 20. Principles of antibiotic resistance.- 21. Clinical approach to treatment of bacterial infections.- 22. Clinical approach to treatment of mycobacterial infections.- 23. Clinical approach to treatment of fungal infections.- 24. Clinical approach to treatment of viral infections.- 25. Sample cases and analyses of the use ofanti-infective agents: Cases 1-15.- Appx A. Common infectious diseases and empiric antibiotic recommendations for adult ed and inpatients at UMass Memorial Medical Center.- Appx B. Bioavailability of anti-infective agents.- Appx C. Dosage and intervals for administration of IV antimicrobials.- Appx D. Dosage and intervals for administration of oral antimicrobials.- Appx E. Important interactions with commonly-used anti-infectives.- Appx F. Oral agents that may have interactions with food.- Appx G. Drug interactions with anti-retroviral agents.- Appx H. Dosage in obesity.- Appx I. Recommendations for management of Asymptomatic Bacteriuria (ASB): 2019 update.- Appx J. Guidelines for treatment of C. difficile.- Appx K. Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression.- Appx L. Guidelines for treatment of adults with community-acquired pneumonia.- Appx M. Guidelines for management of adults with hospital-acquired and ventilator-associated pneumonia.- AppxN. Guidelines for antimicrobial prophylaxis for surgery.- Appx O. Guidelines for treatment and chemoprophylaxis of influenza.- Appx P. Antimicrobial dosing in adult patients on extracorporeal membrane oxygenation (EXMO).- Appx Q. Antimicrobial dosing in neonates.
1. Introduction and history.- 2. Basic principles of drug delivery and dosing.- 3. Sulfonamides.- 4. Penicillins.- 5. Cephalosporins.- 6. Monobactams: Aztreonam.- 7. Carbapenems.- 8. Glycopeptides and other agents used to treat gram-positive cocci.- 9. Vancomycin: New Area-under-the-curve-based therapeutic monitoring.- 10. Aminoglycosides.- 11. Macrolides.- 12. Metronidazole and clindamycin.- 13. Quinolones.- 14. Tetracyclines.- 15. Pleuromutilin.- 16. Antimicrobial stewardship: evolution into the 21st century.- 17. Clinical approach to the treatment of infectious diseases.- 18. Understanding drug allergies and drug toxicities.- 19. Antibiotic-associated diarrhea.- 20. Principles of antibiotic resistance.- 21. Clinical approach to treatment of bacterial infections.- 22. Clinical approach to treatment of mycobacterial infections.- 23. Clinical approach to treatment of fungal infections.- 24. Clinical approach to treatment of viral infections.- 25. Sample cases and analyses of the use ofanti-infective agents: Cases 1-15.- Appx A. Common infectious diseases and empiric antibiotic recommendations for adult ed and inpatients at UMass Memorial Medical Center.- Appx B. Bioavailability of anti-infective agents.- Appx C. Dosage and intervals for administration of IV antimicrobials.- Appx D. Dosage and intervals for administration of oral antimicrobials.- Appx E. Important interactions with commonly-used anti-infectives.- Appx F. Oral agents that may have interactions with food.- Appx G. Drug interactions with anti-retroviral agents.- Appx H. Dosage in obesity.- Appx I. Recommendations for management of Asymptomatic Bacteriuria (ASB): 2019 update.- Appx J. Guidelines for treatment of C. difficile.- Appx K. Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression.- Appx L. Guidelines for treatment of adults with community-acquired pneumonia.- Appx M. Guidelines for management of adults with hospital-acquired and ventilator-associated pneumonia.- AppxN. Guidelines for antimicrobial prophylaxis for surgery.- Appx O. Guidelines for treatment and chemoprophylaxis of influenza.- Appx P. Antimicrobial dosing in adult patients on extracorporeal membrane oxygenation (EXMO).- Appx Q. Antimicrobial dosing in neonates.
1. Introduction and history.- 2. Basic principles of drug delivery and dosing.- 3. Sulfonamides.- 4. Penicillins.- 5. Cephalosporins.- 6. Monobactams: Aztreonam.- 7. Carbapenems.- 8. Glycopeptides and other agents used to treat gram-positive cocci.- 9. Vancomycin: New Area-under-the-curve-based therapeutic monitoring.- 10. Aminoglycosides.- 11. Macrolides.- 12. Metronidazole and clindamycin.- 13. Quinolones.- 14. Tetracyclines.- 15. Pleuromutilin.- 16. Antimicrobial stewardship: evolution into the 21st century.- 17. Clinical approach to the treatment of infectious diseases.- 18. Understanding drug allergies and drug toxicities.- 19. Antibiotic-associated diarrhea.- 20. Principles of antibiotic resistance.- 21. Clinical approach to treatment of bacterial infections.- 22. Clinical approach to treatment of mycobacterial infections.- 23. Clinical approach to treatment of fungal infections.- 24. Clinical approach to treatment of viral infections.- 25. Sample cases and analyses of the use ofanti-infective agents: Cases 1-15.- Appx A. Common infectious diseases and empiric antibiotic recommendations for adult ed and inpatients at UMass Memorial Medical Center.- Appx B. Bioavailability of anti-infective agents.- Appx C. Dosage and intervals for administration of IV antimicrobials.- Appx D. Dosage and intervals for administration of oral antimicrobials.- Appx E. Important interactions with commonly-used anti-infectives.- Appx F. Oral agents that may have interactions with food.- Appx G. Drug interactions with anti-retroviral agents.- Appx H. Dosage in obesity.- Appx I. Recommendations for management of Asymptomatic Bacteriuria (ASB): 2019 update.- Appx J. Guidelines for treatment of C. difficile.- Appx K. Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression.- Appx L. Guidelines for treatment of adults with community-acquired pneumonia.- Appx M. Guidelines for management of adults with hospital-acquired and ventilator-associated pneumonia.- AppxN. Guidelines for antimicrobial prophylaxis for surgery.- Appx O. Guidelines for treatment and chemoprophylaxis of influenza.- Appx P. Antimicrobial dosing in adult patients on extracorporeal membrane oxygenation (EXMO).- Appx Q. Antimicrobial dosing in neonates.
1. Introduction and history.- 2. Basic principles of drug delivery and dosing.- 3. Sulfonamides.- 4. Penicillins.- 5. Cephalosporins.- 6. Monobactams: Aztreonam.- 7. Carbapenems.- 8. Glycopeptides and other agents used to treat gram-positive cocci.- 9. Vancomycin: New Area-under-the-curve-based therapeutic monitoring.- 10. Aminoglycosides.- 11. Macrolides.- 12. Metronidazole and clindamycin.- 13. Quinolones.- 14. Tetracyclines.- 15. Pleuromutilin.- 16. Antimicrobial stewardship: evolution into the 21st century.- 17. Clinical approach to the treatment of infectious diseases.- 18. Understanding drug allergies and drug toxicities.- 19. Antibiotic-associated diarrhea.- 20. Principles of antibiotic resistance.- 21. Clinical approach to treatment of bacterial infections.- 22. Clinical approach to treatment of mycobacterial infections.- 23. Clinical approach to treatment of fungal infections.- 24. Clinical approach to treatment of viral infections.- 25. Sample cases and analyses of the use ofanti-infective agents: Cases 1-15.- Appx A. Common infectious diseases and empiric antibiotic recommendations for adult ed and inpatients at UMass Memorial Medical Center.- Appx B. Bioavailability of anti-infective agents.- Appx C. Dosage and intervals for administration of IV antimicrobials.- Appx D. Dosage and intervals for administration of oral antimicrobials.- Appx E. Important interactions with commonly-used anti-infectives.- Appx F. Oral agents that may have interactions with food.- Appx G. Drug interactions with anti-retroviral agents.- Appx H. Dosage in obesity.- Appx I. Recommendations for management of Asymptomatic Bacteriuria (ASB): 2019 update.- Appx J. Guidelines for treatment of C. difficile.- Appx K. Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression.- Appx L. Guidelines for treatment of adults with community-acquired pneumonia.- Appx M. Guidelines for management of adults with hospital-acquired and ventilator-associated pneumonia.- AppxN. Guidelines for antimicrobial prophylaxis for surgery.- Appx O. Guidelines for treatment and chemoprophylaxis of influenza.- Appx P. Antimicrobial dosing in adult patients on extracorporeal membrane oxygenation (EXMO).- Appx Q. Antimicrobial dosing in neonates.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
